Robuta

https://www.rediff.com/money/2008/jun/12ran.htm
As India's largest drugmaker unveiled a deal worth up to $4.6bn to sell control to Daiichi Sankyo of Japan, the disbelief at the press conference was palpable.
shockindiaranbaxysale
https://www.rediff.com/business/report/ranbaxy-introduces-whistle-blower-policy/20130527.htm
Patient safety and quality our guidance now, says CEO and MD Arun Sawhney.
whistle blowerranbaxyintroducespolicyrediff
https://ranbaxytpplitigation.com/
If you paid for or provided reimbursement for generic Nexium, brand or generic Diovan, or brand or generic Valcyte, you could get a payment from a Class Action
in reranbaxymarketingsalespractices
https://www.industryweek.com/operations/safety/article/21960448/ranbaxy-hit-with-fraud-suit
The suit, filed by Supreme Court lawyer Manohar Lal Sharma, argues that making and selling adulterated drugs is a 'heinous crime' and 'amounts to committing...
ranbaxyhitfraudsuitindustryweek